Lauromacrogol foam injection under ultrasonic guidance for pediatric lip venous malformations
- PMID: 36705764
- DOI: 10.1007/s00383-023-05372-7
Lauromacrogol foam injection under ultrasonic guidance for pediatric lip venous malformations
Abstract
Objective: To evaluate the efficacy and safety of lauromacrogol foam sclerotherapy in the treatment of children with lip venous malformation.
Methods: Fifty-two children (27 males and 25 females) aged from 6 months to 17 years with lip VM who underwent lauromacrogol foam injection with ultrasonic guidance from July 2018 to December 2020 in our hospital were retrospectively recruited for this study. All the children were examined by MRI, ultrasound, blood routine and coagulation before operation. We were guided by ultrasound to locate the blood flow area (nests), injecting lauromacrogol foam to fill the venous malformation. The follow-up time was 14.31 ± 5.96 (6-24) months. Follow-up items include clinical manifestations, imaging data, efficacy and complications.
Results: This group of children was treated 3-5 times, an average of 4 times/case. The total effective rate was 90.38%. Pain in 4 cases, fever in 4 cases, infection in 2 cases, ulcer in 1 case. There were no serious complications such as cardiopulmonary accident.
Conclusion: Ultrasound guiding foam sclerotherapy with lauromacrogol is effective and safe for children with lip venous malformation.
Keywords: Children; Lauromacrogol foam; Lip venous malformation; Sclerotherapy.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.J Vasc Surg. 2009 Apr;49(4):961-7. doi: 10.1016/j.jvs.2008.10.037. J Vasc Surg. 2009. PMID: 19341886
-
[Effect of foam sclerotherapy for the treatment of oropharyngeal venous malformation].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Mar 7;53(3):209-213. doi: 10.3760/cma.j.issn.1673-0860.2018.03.008. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018. PMID: 29614554 Chinese.
-
Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1074-1082. doi: 10.1016/j.jvsv.2019.11.023. Epub 2020 Apr 10. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32284312
-
Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.Eur J Vasc Endovasc Surg. 2011 Mar;41(3):412-7. doi: 10.1016/j.ejvs.2010.10.009. Epub 2010 Dec 15. Eur J Vasc Endovasc Surg. 2011. PMID: 21111641 Review.
-
Sclerotherapy in venous malformation.Phlebology. 2013 Mar;28 Suppl 1:188-91. doi: 10.1177/0268355513477282. Phlebology. 2013. PMID: 23482557 Review.
Cited by
-
Case Report: Combination of sirolimus and endoscopic lauromacrogol sclerotherapy in the management of blue rubber bleb nevus syndrome with gastric tract bleeding.Front Pediatr. 2025 Jan 10;12:1488466. doi: 10.3389/fped.2024.1488466. eCollection 2024. Front Pediatr. 2025. PMID: 39867693 Free PMC article.
References
-
- Hoeger PH (2021) Genes and phenotypes in vascular malformations. Clin Exp Dermatol 46(3):495–502. https://doi.org/10.1111/ced.14513 - DOI - PubMed
-
- Kunimoto K, Yamamoto Y, Jinnin M (2022) ISSVA classification of vascular anomalies and molecular biology. Int J Mol Sci. https://doi.org/10.3390/ijms23042358 - DOI - PubMed - PMC
-
- Kim H, Joh J, Labropoulos N (2022) Characteristics, clinical presentation, and treatment outcomes of venous malformation in the extremities. J Vasc Surg Venous Lymphat Disord 10(1):152–158. https://doi.org/10.1016/j.jvsv.2021.05.011 - DOI - PubMed
-
- Pahl KS, Pabon-Ramos WM, Jeng MR (2022) How we approach localized vascular anomalies. Pediatr Blood Cancer 69(Suppl 3):e29321. https://doi.org/10.1002/pbc.29321 - DOI - PubMed
-
- Carqueja IM, Sousa J, Mansilha A (2018) Vascular malformations: classification, diagnosis and treatment. Int Angiol 37(2):127–142. https://doi.org/10.23736/s0392-9590.18.03961-5 - DOI - PubMed
MeSH terms
Substances
Grants and funding
- Grant No.20200341/Scientific Research Fund of the Health and Health Commission of Hunan Province
- Grant No.20200341/Scientific Research Fund of the Health and Health Commission of Hunan Province
- Grant No.20200341/Scientific Research Fund of the Health and Health Commission of Hunan Province
- Grant No.20200341/Scientific Research Fund of the Health and Health Commission of Hunan Province
- Grant No.20200341/Scientific Research Fund of the Health and Health Commission of Hunan Province
LinkOut - more resources
Full Text Sources